$2.27T
Total marketcap
$126.38B
Total volume
BTC 49.68%     ETH 15.78%
Dominance

Zhejiang Jolly Pharmaceutical Co.,LTD 300181.SZ Stock

13.11 CNY {{ price }} 1.706744% {{change_pct}}%
COUNTRY
China
Exchange
Shenzhen
Market Cap
9.2B CNY
LOW - HIGH [24H]
12.87 - 13.26 CNY
VOLUME [24H]
11.09M CNY
{{ volume }}
P/E Ratio
25.21
Earnings per share
0.52 CNY

Zhejiang Jolly Pharmaceutical Co.,LTD Price Chart

Zhejiang Jolly Pharmaceutical Co.,LTD 300181.SZ Financial and Trading Overview

Zhejiang Jolly Pharmaceutical Co.,LTD stock price 13.11 CNY
Previous Close 12.32 CNY
Open 12.47 CNY
Bid 12.18 CNY x 0
Ask 12.19 CNY x 0
Day's Range 12.18 - 12.63 CNY
52 Week Range 8.1 - 15.55 CNY
Volume 19.15M CNY
Avg. Volume 20.36M CNY
Market Cap 8.94B CNY
Beta (5Y Monthly) 0.292123
PE Ratio (TTM) 26.586954
EPS (TTM) 0.52 CNY
Forward Dividend & Yield 0.3 (2.45%)
Ex-Dividend Date May 30, 2023
1y Target Est 15.12 CNY

300181.SZ Valuation Measures

Enterprise Value 7.77B CNY
Trailing P/E 26.586954
Forward P/E 16.98611
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.8043494
Price/Book (mrq) 3.1119592
Enterprise Value/Revenue 4.177
Enterprise Value/EBITDA 19.202

Trading Information

Zhejiang Jolly Pharmaceutical Co.,LTD Stock Price History

Beta (5Y Monthly) 0.292123
52-Week Change 41.60%
S&P500 52-Week Change 20.43%
52 Week High 15.55 CNY
52 Week Low 8.1 CNY
50-Day Moving Average 13.25 CNY
200-Day Moving Average 11.56 CNY

300181.SZ Share Statistics

Avg. Volume (3 month) 20.36M CNY
Avg. Daily Volume (10-Days) 18.89M CNY
Shares Outstanding 701.39M
Float 477.45M
Short Ratio N/A
% Held by Insiders 30.20%
% Held by Institutions 6.27%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.3
Trailing Annual Dividend Yield 2.43%
5 Year Average Dividend Yield 109.00%
Payout Ratio 0.42029998
Last Split Factor 17:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 16.20%
Operating Margin (ttm) 18.71%
Gross Margin 69.86%
EBITDA Margin 21.75%

Management Effectiveness

Return on Assets (ttm) 7.08%
Return on Equity (ttm) 13.41%

Income Statement

Revenue (ttm) 1.86B CNY
Revenue Per Share (ttm) 2.96 CNY
Quarterly Revenue Growth (yoy) 12.80%
Gross Profit (ttm) 1.27B CNY
EBITDA 404.9M CNY
Net Income Avi to Common (ttm) 301.71M CNY
Diluted EPS (ttm) 0.46
Quarterly Earnings Growth (yoy) 41.79%

Balance Sheet

Total Cash (mrq) 1.04B CNY
Total Cash Per Share (mrq) 1.48 CNY
Total Debt (mrq) 166.16M CNY
Total Debt/Equity (mrq) 5.91 CNY
Current Ratio (mrq) 2.877
Book Value Per Share (mrq) 3.93

Cash Flow Statement

Operating Cash Flow (ttm) 244.87M CNY
Levered Free Cash Flow (ttm) -2022601 CNY

Profile of Zhejiang Jolly Pharmaceutical Co.,LTD

Country China
State N/A
City Huzhou
Address No. 388, Zhiyuan North Road
ZIP 313200
Phone 86 57 2828 1088
Website https://www.zuoli.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 2455

Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.

Q&A For Zhejiang Jolly Pharmaceutical Co.,LTD Stock

What is a current 300181.SZ stock price?

Zhejiang Jolly Pharmaceutical Co.,LTD 300181.SZ stock price today per share is 13.11 CNY.

How to purchase Zhejiang Jolly Pharmaceutical Co.,LTD stock?

You can buy 300181.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Zhejiang Jolly Pharmaceutical Co.,LTD?

The stock symbol or ticker of Zhejiang Jolly Pharmaceutical Co.,LTD is 300181.SZ.

Which industry does the Zhejiang Jolly Pharmaceutical Co.,LTD company belong to?

The Zhejiang Jolly Pharmaceutical Co.,LTD industry is Biotechnology.

How many shares does Zhejiang Jolly Pharmaceutical Co.,LTD have in circulation?

The max supply of Zhejiang Jolly Pharmaceutical Co.,LTD shares is 701.39M.

What is Zhejiang Jolly Pharmaceutical Co.,LTD Price to Earnings Ratio (PE Ratio)?

Zhejiang Jolly Pharmaceutical Co.,LTD PE Ratio is 25.21153800 now.

What was Zhejiang Jolly Pharmaceutical Co.,LTD earnings per share over the trailing 12 months (TTM)?

Zhejiang Jolly Pharmaceutical Co.,LTD EPS is 0.52 CNY over the trailing 12 months.

Which sector does the Zhejiang Jolly Pharmaceutical Co.,LTD company belong to?

The Zhejiang Jolly Pharmaceutical Co.,LTD sector is Healthcare.